BBVA USA Bancshares’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
WRF
RG
BBVA USA Bancshares's GMAB Position: Q1 2021 in Review
BBVA USA Bancshares sold out of Genmab (GMAB) in Q1 2021, closing a stake of 5,409 shares — an estimated $220K sold.
BBVA USA Bancshares first reported a position in GMAB in Q2 2020 and held it in 3 quarters. The position peaked at $281K in Q2 2020. 210 funds tracked by Wall St. Rank hold GMAB as of Q1 2021.
- BBVA USA Bancshares reported no remaining Genmab position as of Q1 2021 after selling out during the quarter.
- BBVA USA Bancshares sold 5,409 Genmab shares in Q1 2021, an estimated $220K.
- BBVA USA Bancshares first reported a position in Genmab in Q2 2020 and held it in 3 quarters.
- BBVA USA Bancshares's Genmab position peaked at $281K in Q2 2020.
- 210 funds tracked by Wall St. Rank held Genmab as of Q1 2021.
Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.